Citations

Showing 10 of 108094 citations.

Predictors of anemia response to momelotinib therapy in myelofibrosis and impact on survival
Gangat, Naseema , Begna, Kebede H. , Al‐Kali, Aref , Litzow, Mark R. , Pardanani, Animesh , Tefferi, Ayalew , Litzow, Mark R. , Pardanani, Animesh , Tefferi, Ayalew , Hogan, William J.

Mayo Clinic

American Journal of Hematology | November 9, 2022 | Volume: 98 | Issue: 2 | Pages: 282-289

10.1002/ajh.26778 | PMID 36349465 Get It

AbstractWe retrospectively reviewed 72 anemic patients with myelofibrosis (MF; median age 68 years), who were JAK2 inhibitor‐naïve at the time of study entry to a phase‐1/2 momelotinib clinical trial. Driver mutation profile included JAK2 69%, CALR 17%, MPL 8%, and triple‐negative 6%; other mutations included ASXL1 39% and SRSF2 17%. Momelotinib was administered at a median dose of 300 mg daily. Anemia response was assessed by formal criteria and documented in 44% of all patients with hemoglobin levels below the sex‐adjusted reference range (n = 72), 48% of those with hemoglobin <10 g/dl (n = 54), and 46% of those who were transfusion‐dependent at the time of study entry (n = 28). Anemia response was more likely with post‐essential thrombocythemia MF (83% vs 37%; p = .001), lower serum ferritin (p = .003), and shorter time from diagnosis to momelotinib therapy (p = .001); the first two variables were also predictive in transfusion‐dependent patients. Post‐momelotinib median survival was 3.2 years; in univariate analysis, survival was superior in anemia responders (median 3.8 vs. 2.8 years; p = .14) and in the presence of type 1/like CALR mutation and inferior in the presence of age > 65 years, ASXL1/SRSF2 mutation, unfavorable karyotype, DIPSS‐plus high risk, red cell transfusion need and higher serum ferritin. Multivariable analysis confirmed the favorable impact of anemia response on survival (p = .02; HR 0.5, 3/5/10‐year survival; 69%/38%/25%). This survival advantage was also noted in transfusion‐dependent patients (3.7 vs. 1.9 years; p = .01; HR 0.3) and appeared to be restricted to patients with an unfavorable genetic profile. The current study suggests a short‐term survival benefit associated with anemia response in momelotinib‐treated patients with MF.
Phase IIIb study of the bevacizumab biosimilar candidate BI 695502 plus mFOLFOX6 in metastatic colorectal cancer
Bekaii‐Saab, Tanios , Balser, Sigrid , Lohmann, Ragna, Daoud, Hasan, Liedert, Bernd, Schliephake, Dorothee E., Bekaii-Saab, Tanios S

Mayo Clinic

Colorectal Cancer | November 9, 2022 | Volume: 11 | Issue: 1 | Pages: No page available

10.2217/crc-2022-0002 Get It

Right atrial collapse in the absence of pericardial effusion
Farina, Juan M. , Jaroszewski, Dawn E. , Aly, Mohamed R., Botros, Michael, Chaliki, Hari P. , Farina, Juan M

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | November 9, 2022 | Volume: 24 | Issue: 1 | Pages: e21-e21

10.1093/ehjci/jeac208 | PMID 36347763 Get It

Prognostic and therapeutic interest of a new classification in inferior hip dislocation: a systematic review of the literature
Severyns, Mathieu , Odri, Guillaume , Flurin, Laure

Mayo Clinic

HIP International | November 9, 2022 | Volume: 33 | Issue: 6 | Pages: 992-1016

10.1177/11207000221134016 | PMID 36348521 Get It

Introduction: Reported cases of inferior dislocation in the literature are found under several names (inferior, anteroinferior, obturator, or erecta), which may be source of confusion. The purpose of this comprehensive review of the literature is to collect as many cases of inferior dislocation as possible to determine better therapeutic strategies, outcome after reduction, complications, and prognostic factors. Methods: In April 2020, a literature search was performed in Pubmed, Medline, Scopus, Cochrane, and Embase databases. The MeSH keywords were “OBTURATOR DISLOCATION HIP” or “ANTERIOR DISLOCATION HIP” or “INFERIOR DISLOCATION HIP.” Authors independently selected articles that met the selection criteria, with no time limit. Results: Out of the 97 articles selected, there were 119 cases of primary inferior hip dislocations. This review of the literature has allowed us to differentiate 3 radiographic subtypes of inferior dislocations, which correspond to 3 different anatomical positions of the femoral head: “obturator” dislocation, “proximal anterior-inferior” dislocation, and “distal anterior-inferior” dislocation. Our subtype classification yielded 39 obturator subtype inferior dislocations (32.8%), 66 proximal anteroinferior subtypes (55.4%), and 14 distal anteroinferior (11.8%). The obturator subtype is at risk of reduction failure and femoral neck fracture during the reduction manoeuver. Conclusions: Our study identified 3 subtypes with different prognosis, with obturator and distal anteroinferior dislocations having a poorer prognosis because of their pre- and post-reduction complications. We were unable to determine the correct manoeuver to reduce inferior dislocations without taking the risk of femoral neck fracture, but each of these subtypes may require a different manoeuver.
Small Bowel Obstruction Conservatively Managed in Hospital-At-Home
Paulson, Margaret R. , Eldaly, Abdullah S. , Ávila, Francisco R. , Torres‐Guzman, Ricardo A. , Maita, Karla C. , Garcia, John P. , Serrano, Luiza Palmieri , Emam, Omar S. , Forte, Antonio J. , Maniaci, Michael J. , Forte, Antonio Jorge , Torres, Ricardo A , Eldaly, Abdullah , Palmieri-Serrano, Luiza , Maniaci, Michael J , Avila, Francisco R , Garcia, John P , Paulson, Margaret R

Mayo Clinic

Case Reports in Gastrointestinal Medicine | November 8, 2022 | Volume: 2022 | Issue: No issue available | Pages: 1-5

10.1155/2022/1969040 | PMID 36398066 Get It

In 2020, Mayo Clinic established an Advanced Care at Home (ACH) program. ACH is a virtual hybrid hospital-at-home (HaH) program that combines telemedicine with in-home care services by utilizing a state that is software-driven, vendor-mediate medical supply chain. The program initially focused on acute medical diagnosis but has expanded to oversee surgical and postsurgical patients with continued inpatient needs. Here, we report the first case of a small bowel obstruction (SBO) managed under a HaH program. A 52-year-old lady presented to the emergency department with symptoms suggestive of mechanical SBO. The diagnosis was confirmed with an abdominopelvic computed tomography (CT) scan, and the patient was admitted to the hospital. Based on the patient’s presentation and laboratory results, the care team proceeded with conservative treatment including nasogastric tube (NG) placement and suctioning, intravenous (IV) fluid replacement, and daily laboratory studies. She spent the first hospital day in the physical hospital ward so that the surgical team could ensure stability clinically and no urgent need for surgical intervention. On hospital day two, she was transferred home with ACH where the NG suctioning and IV replacement therapy could continue, while the medical team conducted daily virtual visits to ensure continued improvement. Additionally, a paramedic and a nurse performed an in-person, head-to-toe assessment and administered medications to the patient twice daily. She spent 5 days in ACH getting acute care and then was discharged into a postacute phase equivalent to outpatient monitoring called the restorative phase. She was monitored remotely for the duration of the restorative phase for 10 more days, and then she recovered fully. This case highlights that high-acuity patients with SBO can receive invasive treatments like NG tube suction as well as be appropriately monitored for clinical decompensation by a virtual hybrid home hospital program which combines virtual care providers with an in-home vendor-mediated supply chain.
Moving toward health equity: the influence of race and ethnicity on choice and quality of life of menopause treatment in midlife women
David, Paru S., Kling, Juliana M.

Mayo Clinic

Menopause | November 8, 2022 | Volume: 29 | Issue: 12 | Pages: 1353-1354

10.1097/gme.0000000000002116 | PMID 36346986 Get It

Impaired Diurnal Pattern of Meal Tolerance and Insulin Sensitivity in Type 2 Diabetes: Implications for Therapy
Yadav, Yogesh , ROMERES, DAVIDE, Cobelli, Claudio , Man, Chiara Dalla , Carter, Rickey E. , Basu, Ananda , Basu, Rita , Dalla Man, Chiara , Carter, Rickey, Cobelli, Claudio , Carter, Rickey E , Basu, Rita

Mayo Clinic

Diabetes | November 8, 2022 | Volume: 72 | Issue: 2 | Pages: 223-232

10.2337/db22-0238 | PMID 36346619 Get It

To assess the diurnal patterns of postprandial glucose tolerance and insulin sensitivity, 19 subjects with type 2 diabetes (8 women; 60 ± 11 years; BMI 32 ± 5 kg/m2) and 19 anthropometrically matched subjects with no diabetes (ND; 11 women; 53 ± 12 years; BMI 29 ± 5 kg/m2) were studied during breakfast (B), lunch (L), and dinner (D) with identical mixed meals (75 g carbohydrates) on 3 consecutive days in a randomized Latin square design. Three stable isotopes of glucose were ustilized to estimate meal fluxes, and mathematical models were used in estimating indices of insulin action and β-cell function. Postmeal glucose excursions were higher at D versus B and at D versus L in type 2 diabetes (P &lt; 0.05), while in ND they were higher at D versus B (P = 0.025) and at L versus B (P = 0.04). The insulin area under the curve was highest at B compared with L and D in type 2 diabetes, while no differences were observed in ND. Disposition index (DI) was higher at B than at L (P &lt; 0.01) and at D (P &lt; 0.001) in ND subjects, whereas DI was low with unchanging pattern across B-L-D in individuals with type 2 diabetes. Furthermore, between-meal differences in β-cell responsivity to glucose (F) and insulin sensitivity (SI) were concurrent with changes in the DI within groups. Fasting and postmeal glucose, insulin, and C-peptide concentrations, along with estimates of endogenous glucose production (EGP), Rd, SI, F, hepatic extraction of insulin, insulin secretion rate, extracted insulin, and DI, were altered in type 2 diabetes compared with ND (P &lt; 0.011 for all). The data show a diurnal pattern of postprandial glucose tolerance in overweight otherwise glucose-tolerant ND individuals that differs from overweight individuals with type 2 diabetes. The results not only provide valuable insight into management strategies for better glycemic control in people with type 2 diabetes, but also improved understanding of daytime glucose metabolism in overweight individuals without impaired glucose tolerance or overt diabetes.
Financial Impact of a Culturally Sensitive Hispanic Kidney Transplant Program on Increasing Living Donation
Mathur, Amit K. , Ruiz, Richard , Wang, Andrew , Caicedo, Juan Carlos , Gordon, Elisa J.

Mayo Clinic

Transplantation | November 8, 2022 | Volume: 107 | Issue: 4 | Pages: 970-980

10.1097/tp.0000000000004382 | PMID 36346212 Get It

Background. In the United States, Hispanic/Latinx patients receive disproportionately fewer living donor kidney transplants (LDKTs) than non-Hispanic White patients. Northwestern Medicine’s culturally targeted Hispanic Kidney Transplant Program (HKTP) was found to increase LDKTs in Hispanic patients at 1 of 2 transplant programs with greater implementation fidelity. Methods. We conducted a budget impact analysis to evaluate HKTP’s impact on program financial profiles from changes in volume of LDKTs and deceased donor kidney transplants (DDKTs) in 2017 to 2019. We estimated HKTP programmatic costs, and kidney transplant (KT) program costs and revenues. We forecasted transplant volumes, HKTP programmatic costs, and KT program costs and revenues for 2022–2024. Results. At both programs, HKTP programmatic costs had <1% impact on total KT program costs, and HKTP programmatic costs comprised <1% of total KT program revenues in 2017–2019. In particular, the total volume of Hispanic KTs and HKTP LDKTs increased at both sites. Annual KT program revenues of HKTP LDKTs and DDKTs increased by 226.9% at site A and by 1042.9% at site B when comparing 2019–2017. Forecasted HKTP LDKT volume showed an increase of 36.4% (site A) and 33.3% (site B) with a subsequent increase in KT program revenues of 42.3% (site A) and 44.3% (site B) among HKTP LDKTs and DDKTs. Conclusions. HKTP programmatic costs and KT evaluation costs are potentially recoverable by reimbursement of organ acquisition costs and offset by increases in total KT program revenues of LDKTs; transplant programs may find implementation of the HKTP financially manageable.
Cochlear promontory anatomy relevant to development of subendosteal and transpromontory electrodes using 192‐section ultra‐high resolution temporal bone CT imaging
Marinelli, John P. , Patel, Neil S. , Lohse, Christine M. , Lane, John I. , Carlson, Matthew L.

Mayo Clinic

Laryngoscope Investigative Otolaryngology | November 8, 2022 | Volume: 7 | Issue: 6 | Pages: 2084-2087

10.1002/lio2.965 | PMID 36544948 Get It

AbstractObjectiveTo characterize normative adult ranges for cochlear promontory thickness relevant to the development of subendosteal and transpromontory electrodes to rehabilitate various neurotologic disorders.PatientsAdults (≥18 years).InterventionIn vivo radiologic assessment using a 192‐slice CT scanner (Force‐192; Siemens Healthcare) with ultrahigh‐resolution scan mode combined and iterative reconstruction.Main Outcome MeasureCochlear promontory thickness.ResultsAmong 48 included patients (96 ears), the mean (SD) age was 56 (18) years (range 25–94) and included 25 (52%) women. Of that 12 patients (25%) had osteopenia (n = 6) or osteoporosis (n = 6). The mean (SD) body mass index was 28 (5) kg/m2. The mean (SD) promontory thickness for the 96 temporal bones under study was 1.22 (0.24) mm (range 0.55–1.85). There was not a statistically significant association between age and promontory thickness (correlation coefficient .08; p = .44). Promontory thickness was significantly greater for men than women (mean 1.28 vs. 1.17 mm; p = .03) and increased with increasing body mass index (correlation coefficient .30; p = .004). Last, promontory thickness was significantly less for patients with osteopenia or osteoporosis compared with those without these conditions (mean 1.09 vs. 1.27 mm; p = .002).ConclusionsCochlear promontory thickness can vary by almost 1.5 mm across patients and is significantly associated with patient sex, body mass index, and comorbid osteopenia/osteoporosis. Subendosteal and transpromontory electrode placement techniques must account for this degree of variability.Level of EvidenceIV
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
Belhadj, Sami , Khurram, Aliya , Bandlamudi, Chaitanya , Palou-Márquez, Guillermo , Steinsnyder, Zoe , Wildman, Temima , Catchings, Amanda , Kemel, Yelena , Mukherjee, Semanti , Fesko, Benjamin , Mehine, Miika , Dandiker, Sita , Izhar, Aalin , Nathanson, Katherine L. , Brower, Jamie , Walsh, Michael F. , Topka, Sabine , Offit, Kenneth , Ravichandran, Vignesh , Steinsnyder, Zoe , Wildman, Temima , Catchings, Amanda , Kemel, Yelena , Mukherjee, Semanti , Fesko, Benjamin , Arora, Kanika , Mehine, Miika , Dandiker, Sita , Izhar, Aalin , Petrini, John , Domchek, Susan M , Nathanson, Katherine L , Brower, Jamie , Couch, Fergus J. , Stadler, Zsofia , Robson, Mark , Walsh, Michael , Joseph, Vijai , Berger, Michael , Supek, Fran , Karam, Rachid , Topka, Sabine , Offit, Kenneth , Ravichandran, Vignesh , Domchek, Susan M. , Couch, Fergus J. , Robson, Mark E. , Vijai, Joseph , Karam, Rachid

Mayo Clinic

Clinical Cancer Research | November 8, 2022 | Volume: 29 | Issue: 2 | Pages: 422-431

10.1158/1078-0432.ccr-22-1703 | PMID 36346689 Get It

Abstract Purpose: To explore the role of NBN as a pan-cancer susceptibility gene. Experimental Design: Matched germline and somatic DNA samples from 34,046 patients were sequenced using Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets and presumed pathogenic germline variants (PGV) identified. Allele-specific and gene-centered analysis of enrichment was conducted and a validation cohort of 26,407 pan-cancer patients was analyzed. Functional studies utilized cellular models with analysis of protein expression, MRN complex formation/localization, and viability assessment following treatment with γ-irradiation. Results: We identified 83 carriers of 32 NBN PGVs (0.25% of the studied series), 40% of which (33/83) carried the Slavic founder p.K219fs. The frequency of PGVs varied across cancer types. Patients harboring NBN PGVs demonstrated increased loss of the wild-type allele in their tumors [OR = 2.7; confidence interval (CI): 1.4–5.5; P = 0.0024; pan-cancer], including lung and pancreatic tumors compared with breast and colorectal cancers. p.K219fs was enriched across all tumor types (OR = 2.22; CI: 1.3–3.6; P = 0.0018). Gene-centered analysis revealed enrichment of PGVs in cases compared with controls in the European population (OR = 1.9; CI: 1.3–2.7; P = 0.0004), a finding confirmed in the replication cohort (OR = 1.8; CI: 1.2–2.6; P = 0.003). Two novel truncating variants, p.L19* and p.N71fs, produced a 45 kDa fragment generated by alternative translation initiation that maintained binding to MRE11. Cells expressing these fragments showed higher sensitivity to γ-irradiation and lower levels of radiation-induced KAP1 phosphorylation. Conclusions: Burden analyses, biallelic inactivation, and functional evidence support the role of NBN as contributing to a broad cancer spectrum. Further studies in large pan-cancer series and the assessment of epistatic and environmental interactions are warranted to further define these associations.